BioCentury | Feb 12, 2021
Finance
Public listing, Phase II cancer readouts in Cyteir’s sights as it banks $80M crossover round
...in the round were Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, Ample Plus Fund...